Skip to main content
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 2021 Mar 12;102(2):74–79. doi: 10.1111/iep.12387

Modelling hypercholesterolaemia in rats using high cholesterol diet

Luiza Ferracini Cunha 1, Mariana Aubin Ongaratto 2, Marcelo Endres 2, Alethea Gatto Barschak 1,
PMCID: PMC7981591  PMID: 33710712

Abstract

Hypercholesterolaemia is a complex condition with multiple causes, including both lifestyle and genetic aspects. It is also a risk factor for cardiovascular diseases (CVDs), which are responsible for 172 million deaths/year. Although the reasons for hypercholesterolaemia are known, there are many critical questions that remain to be answered so that new therapeutics can be developed. In order to elucidate the pathobiology of this condition, animal models can mimic the pathology of human hypercholesterolaemia. One example of an animal model is induced by the hypercholesterolaemic diet in Wistar rats. The present review first summarizes the current understanding of the metabolic profile involved in hypercholesterolaemia in humans. Next it comments about the lack of consensus as to which hypercholesterolaemia induction protocol should be used. The present work aimed to review experimental studies that induced hypercholesterolaemia in Wistar rats it was not intended to judge the “best” model, since they all achieved the goal of inducing an increase in serum cholesterol.

Keywords: dyslipidaemia, hypercholesterolaemia, nutrition, Wistar rats

1. INTRODUCTION

Cardiovascular diseases (CVDs) are responsible for 17.2 million deaths/year all over the world. 1 There is a constant search for long term alternative dietary treatments, since this kind of disease starts appearing at early age. 2 CVDs are included in the group of chronic non‐communicable diseases, which also include obesity, systemic arterial hypertension (SAH), diabetes mellitus type 2 (DM2), dyslipidaemia and cancer. 3

There is a strong relation between CVSs and genetic, environmental and lifestyle factors. When these conditions are aligned with other risk factors for CVD, the possibility of coronary artery disease increases exponentially. 4 The main risk factors for CVD are high total cholesterol, SAH, reduced HDL cholesterol, DM2 and age. 5

Increased serum total cholesterol and low LDL cholesterol are components of hypercholesterolaemia. Besides being a risk factor for cardiovascular diseases, these alterations can also be harmful to the organism in other ways. Hypercholesterolaemia can be classified as primary when the lipid disorder has genetic influence, or secondary, caused by inadequate diet and lifestyle, as well as medications. 6

The decrease in serum cholesterol levels can be achieved by the consumption of appropriate food, specific foods and/or drugs. Foods and drugs which have hypocholesterolaemic effects should be tested in vitro and in vivo before being consumed by humans in order to verify their efficacy and safety. 7 , 8

Hypercholesterolaemia, as one of the main risk factors for CVD, has been studied extensively in animal models, especially as part of the search for new therapeutic approaches. However, there is no consensus about which hypercholesterolaemic induction protocol should be used. Therefore the present work aimed to review experimental studies that induced hypercholesterolaemia in Wistar rats.

2. METABOLIC PROFILE OF HYPERCHOLESTEROLAEMIC HUMANS

Before studying the effects of hypercholesterolaemic diet in animals, it is important to understand the cholesterol metabolism in humans; thus, thereafter, the similarity with between animals and humans can be verified.

Cholesterol is a vital compound, essential in cell membrane formation, sex hormone production and bile salt formation, among other functions of the organism. 9 It can be found in animal fats, basically in its free form. Its main food sources are egg yolk, milk and milk derivates, shrimp, beef, bird skin and viscera. Some classic studies have shown a strong association between high cholesterol consumption and increased incidence of atherosclerosis. 10 , 11 Despite that, it is known that 56% of dietetic cholesterol is absorbed, and other fatty acids also have influence on plasmatic cholesterol concentration. 9

Cholesterol circulates in the bloodstream in structures called lipoproteins, formed by lipids and proteins. These are classified according to their composition (chylomicrons and VLDL—rich in triglycerides; LDL—rich in cholesterol; and HDL—rich in cholesterol and proteins). 6

Atherosclerosis can be classified as a chronic inflammatory disease of multifactorial origin, which mainly affects medium‐ and large‐calibre arteries reducing blood flow. The initial injuries are originated in childhood and are characterized by cholesterol accumulation in macrophages. The deposition of lipoproteins in the arterial wall, a key process at the beginning of atherogenesis, occurs in proportion with the plasma lipoprotein concentration. The severity of atherosclerosis is related to classic risk factors, such as dyslipidaemia, diabetes, tobacco addiction, hypertension and others. At the cellular level, cholesterol crystals, microfilaments released by neutrophils, ischaemia and changes in haemodynamic drag pressure have been implicated in the activation of the inflammatory process, which is associated with atherosclerotic plaque rupture or endothelial erosion. 12

The implications of this are that the tissue factor of the vascular intima interacts with circulating VIIa factor, leading to thrombin generation, platelet activation and thrombus formation, thereby determining the main complications of atherosclerosis, acute myocardial infarction and cerebrovascular accident (stroke). 6

Taking into account both physiology and metabolism, Wistar rats have been shown to be a very useful animal model to evaluate both hypercholesterolaemia and the comorbidities of metabolic syndrome due to their similarity to humans. 13

3. DATA COLLECTION

Articles were found using the keywords “Hypercholesterolemia OR Hyperlipidemias AND Diet AND Rats, Wistar” in PubMed and “Hypercholesterolemia OR Hyperlipidemias AND Diet AND Rats Wistar” in BVS (Biblioteca Virtual de Saúde, a Brazilian database). We included data from experimental studies that efficiently induced hypercholesterolaemia through diet in Wistar rats from 2013 until 2017. We excluded articles that induced hypercholesterolaemia by injection, drug tests and reviews. Studies that did not have a control group were also excluded as in that case we could not prove and quantify the induction. The data collection consisted of three phases: title evaluation, abstract evaluation and full‐text evaluation. Two researchers analysed the manuscripts. The findings are summarized in Table 1.

TABLE 1.

Summary of hypercholesterolaemic diet–fed rat studies

Author Year Initial age/ body weight Diet composition Diet duration Serum cholesterol diet group—comparison with the control group
38 2013 4 wk ± 100 g 5 g/kg cholesterol, 2.5 g/kg sodium chloride 14 d 11.2 ± 0.6 mmol/L a —increased
23 2013

8 wk

250‐300 g

2% cholesterol, 0.2% colic acid 60 d 127 ± 6.5 mg/dL—increased
39 2013 ±175g 1, 0.5% cholesterol, 0.2% NaTDC, 5% sugar, 0.05% propylthiouracil 28 d 5.98 ± 1.07 mmol/L a —increased
14 2013 140‐160 g 1% cholesterol 8 wk 114.26 ± 1.67 mg/dL—increased
40 2013 90 g 2.43% cholesterol, 0.49% cholic acid 1 wk 2.23 ± 0.19 mmol/L a —increased
48 2013

180‐200 g

3% cholesterol, 0.2% cholic acid, 0.5% propylthiouracil, 10% lard 4 wk 19 ± 0.11 mmol/L a —increased
24 2013

8 wk

250 g

33.5% lard, 1.5% soya bean oil 7 wk 53 ± 3.4 mg/dL—increased
33 2013

6‐8 wk

180‐210 g

1% cholesterol, 2% coconut oil 60 d 168.55 ± 14.69 mg/dL—increased
27 2013 180‐210 g 10 g lard, 4 g corn oil, 0.15 g margarine 15 d 223.91 ± 20.4 mg/dL—increased
41 2013

6 wk

170‐200 g

2% cholesterol, 0.25% cholic acid 8 wk Values not informed—serum cholesterol significantly increased
42 2014 ±140 g 4% cholesterol, 1% cholic acid, 0.5% thiouracil 17 d 153.63 ± 11.72 mg/dL—increased
26 2014

8 wk

150‐200 g

2% cholesterol, 0.2% cholic acid. 5% lard 3 mo Values not informed—serum cholesterol significantly increased
28 2014 190‐230 g 1% cholesterol, 0.2% bile salts, 10% lard, 10% yolk powder 42 d 2.65 ± 0.17 mmol/L a —increased
43 2015

4 wk

80‐100 g

12.5% palm oil, 12.5% lard, 5% cholesterol, 2% cholic acid 30 d 150.29 ± 20.51 mg/dL—increased
37 2015

1 y

500 g

16.3 g/kg cholesterol 8 wk 3.3 ± 0.34 mmol/L a —increased
17 2015 ±200 g 1% cholesterol 28 d Values not informed—serum cholesterol significantly increased
44 2015 200‐300 g 365 g/kg cholesterol, 310 g/kg yard 6 wk 252.17 ± 14.72 mg/dL—increased
45 2015 150‐200 g 100 g/kg corn oil 7 wk 131 ± 9.6 mg/dL—increased
19 2016 4‐6 wk 2% cholesterol 60 d 194.2 ± 35.6 mg/dL—increased
18 2016 190‐210 g 2% cholesterol 9 wk 88.4 (74.5‐100.3) mg/dl—increased
30 2016 170‐190 g 60% lard 90 d 194.2 ± 35.6 mg/dL—increased
47 2016

8 wk

250 g

33.5% lard, 1.5% soya bean oil 5 wk 46.0 ± 3.2 mg/dL—increased

25

2016

8 wk

180‐220 g

10% lard, 20% sucrose, 2% cholesterol, 1% bile salt 8 wk Values not informed—serum cholesterol significantly increased
16 2016 ±114 g 1% cholesterol 42 d 2.25 ± 1.07 mmol/L a —increased
36 2017 ±110 g 1% cholesterol, 10% yolk powder, 5% lard 10 wk Values not informed—serum cholesterol significantly increased
22 2017

8 wk

200‐300 g

6% cholesterol 6 wk 151.00 ± 10.74 mg/dL—increased
20 2017

8 wk

245 ± 5 g

2% cholesterol, 0.5% cholic acid 7 wk 198.25 ± 10.61 mg/dL—increased
15 2017 ±178 g 1% cholesterol 4 wk 156.09 ± 0.92 mg/dL—increased
29 2017

1 y

±500 g

1.26% cholesterol, 0.25% cholic acid 8 wk 126.9 ± 13.2 mg/dL—increased
20 2017 250 g 2% cholesterol, 0.5% cholic acid 7 wk Values not informed—serum cholesterol significantly increased
34 2017 ±180 g 10% sheep's fat, 0.1% cholic acid 6 wks 1.14 ± 0.03 mmol/L a —increased
35 2017 ±190 g 10 g/kg cholesterol, 1g/kg cholic acid 2 mo 3.21 ± 0.12 mmol/L a —increased
32 2017 ±180 g 400 g/kg beef tallow 12 wk 53.26 ± 1.90 mg/dL—increased
46 2017

4 wk

120‐150 g

15% lard, 10% custard powder, 1.2% cholesterol, 0.3% sodium taurocholate 28 d Values not informed—serum cholesterol significantly increased
a

Conversion factor: 1 mmol/L = 18.018 mg/dL.

4. PATTERNS OF HYPERCHOLESTEROLAEMIC INDUCTION

Of the 208 articles initially analysed, 33 met the inclusion criteria and were included in the present study. It is noticable that the most commonly used protocol for inducing hypercholesterolaemia was the addition of 1% cholesterol to animal diets which appears in 12.1% of the analysed articles, 14 , 15 , 16 , 17 followed by the addition of 2% cholesterol 18 , 19 and 2% cholesterol + 0.5% cholic acid, 20 , 21 Both of the latter protocols were used by 6% of the analysed articles. Only one study used each of the other listed protocols. Eight of the studies analysed did not add cholesterol to the diet and still managed to obtain induction.

Concerning the study time, 5 articles used the 8‐week protocol. 21 , 22 , 23 , 24 , 25 , 26 The shortest study time was 15 days, and it used 10 g lard, 4 g corn oil and 0.15 g margarine added to the diet. 27

Regarding the age of the animals, most studies used animals aged 6‐8 weeks at the beginning of the study, though some articles provided only the weight of the animals and not the initial age, therefore not allowing a complete analysis.

All articles claim to have been able to induce hypercholesterolaemia in animals and consequently were included in the present study. However, some of them did not provide the total serum cholesterol values at the beginning and end of the study, making it impossible to verify and quantify the induction.

5. IMPACT OF THE HYPERCHOLESTEROLAEMIC DIET

The regulation of bile acids in the body depends on cholesterol, and this causes cholesterol to modify the composition of bile salts in various parts of the organism, including faecal excretion. 18 , 21 Wang et al demonstrated in their study a smaller faecal bolus in the high cholesterol diet group, 28 although no evidence of this has been found in other studies.

The induction of hypercholesterolaemia can lead to obesity, even when the amount of lipids in control and hypercholesterolaemic groups is the same. 15 , 21 , 28 Santos‐Lopez et al observed that animals fed with a high cholesterol diet developed weight loss, even without significant difference in energy consumption when compared to the control group animals. 29

Hypercholesterolaemia induced by diet also affects the animal's liver, increasing its weight and causing damage. These alterations are probably caused by the higher fat content in the liver. 30 , 31 , 32 Furthermore, some studies correlate the liver damage with the high fatty acid content in the diet. However, other studies, in which the fat content was not modified, have also observed hepatic damage in the animals. 16 , 19 , 28 , 33 Some studies have found increased weight of heart and kidneys as well. 7 , 19

The induction of hypercholesterolaemia additionally decreases the activity of some superoxide dismutase (SOD) and catalase (CAT) (important antioxidant enzymes) in the liver, which also decreases the antioxidant defence. 32 , 34 , 35 In addition, hypercholesterolaemic diet can lower vitamin C levels in the animal's body. 35

In animals with hypercholesterolaemia there is a decrease in myocardium function, increasing the chance of ischaemia and reperfusion and enlarging the size of infarction. However, the mechanism involved in these alterations is still not known. 7 , 18 , 36

The animal's age may influence diet consumption, and this directly affects weight gain throughout the experiment. 37

The major limitation of our study is that there is not much information about the impact of the hypercholesterolaemic diet itself. This diet is generally used as a positive control, and the studies do not show significant results exclusively in the hypercholesterolaemic group.

6. LIMITATIONS

The main limitation of this study is the fact that the articles analysed were not intended to examine the model, but the cholesterol reduction parameters instead. Thus, many of the papers do not illustrate cholesterol data accurately.

7. CONCLUSION

The current study reviewed hypercholesterolaemic models induced by diet and analysed many protocols that induce hypercholesterolaemia in animals with different ages and diets. The aim was to collect information, rather than judge the best model, considering that they all achieved their primary goal of inducing an increase in serum cholesterol. Even so, it was noted that the most commonly used protocol for hypercholesterolaemic induction is the addition of 1% cholesterol to animal diets.

Cunha LF, Ongaratto MA, Endres M, Barschak AG. Modelling hypercholesterolaemia in rats using high cholesterol diet. Int J Exp Path. 2021;102:74–79. 10.1111/iep.12387

The present review summarizes the current understanding of the metabolic profile involved in hypercholesterolaemia in rats.

REFERENCES

  • 1. WHO . (2003). Diet, nutrition and the prevention of chronic diseases. [PubMed]
  • 2. Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the third national health and nutrition examination survey 1. Prev Med. 1998;27:879‐890. [DOI] [PubMed] [Google Scholar]
  • 3. Duncan BB, Chor D, Aquino EML, et al. Doenças Crônicas Não Transmissíveis no Brasil: Prioridade para enfrentament e investigação. Rev Saude Publica. 2012;46(SUPPL.1):126‐134. [DOI] [PubMed] [Google Scholar]
  • 4. Castro LCV, Franceschini SDCC, Priore SE, Pelúzio MDCG. Nutrição e doenças cardiovasculares: Os marcadores de risco em adultos. Revista de Nutricao. 2004;17(3):369‐377. [Google Scholar]
  • 5. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837‐1847. [DOI] [PubMed] [Google Scholar]
  • 6. de Cardiologia SB. Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose ‐ 2017. Arq Bras Cardiol. 2017;109(1):1‐7. [DOI] [PubMed] [Google Scholar]
  • 7. Xie Y, Zhang H, Liu H, et al. Hypocholesterolemic effects of Kluyveromyces marxianus M3 isolated from Tibetan mushrooms on diet‐induced hypercholesterolemia in rat. Braz J Microbiol. 2015;46(2):389‐395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Yang L, Han G, Liu QH, et al. Rice protein exerts a hypocholesterolemic effect through regulating cholesterol metabolism‐related gene expression and enzyme activity in adult rats fed a cholesterol‐enriched diet. Int J Food Sci Nutr. 2013;64(7):836‐842. [DOI] [PubMed] [Google Scholar]
  • 9. Santos RD, Gagliardi AC, Xavier HT, Magnoni CD, Cassani R, Lottenberg AM. I Diretriz sobre o consumo de gorduras e saúde cardiovascular. Sociedade Bras Cardiol. 2013;100(Suplemento 3):1‐40. [PubMed] [Google Scholar]
  • 10. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet. Metab Clin Exp. 1965;14(7):759‐765. [DOI] [PubMed] [Google Scholar]
  • 11. Walker BARP, Arvidsson UB. Fat intake, serum cholesterol concentration, and atherosclerosis in the south african Bantu. Part I. Low fat intake and the age trends of serum cholesterol concentration in the south african Bantu. J Clin Invest. 1953;20:1358‐1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Ridker PM, Medical H. From CRP to IL‐6 to IL‐1: moving upstream to identify novel targets for Atheroprotection. Circ Res 2016;118(1):145‐156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Joris I, Zand T, Nunnari J, Krolikowsky J, Majno G. Pathogenesis aorta of hypercholesterolemic rats. Atherosclerosis. 1983;341‐358. [PMC free article] [PubMed] [Google Scholar]
  • 14. El Rabey HA, Al‐Seeni MN, Amer HM. Efficiency of barley bran and oat bran in ameliorating blood lipid profile and the adverse histological changes in hypercholesterolemic male rats. Biomed Res Int. 2013;2013:1‐10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Fidèle N, Joseph B, Emmanuel T, Théophile D. Hypolipidemic, antioxidant and anti‐atherosclerogenic effect of aqueous extract leaves of Cassia. occidentalis Linn (Caesalpiniaceae) in diet‐induced hypercholesterolemic rats. BMC Complement Altern Med. 2017;17(1):76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Leontowicz M, Leontowicz H, Jesion I, et al. Kiwifruit Actinidia arguta supplementation protects aorta and liver in rats with induced hypercholesterolemia. Nutr Res. 2016;36(11):1231‐1242. [DOI] [PubMed] [Google Scholar]
  • 17. Wang Q, Du Z, Zhang H, et al. Modulation of gut microbiota by polyphenols from adlay (Coix lacryma‐jobi L. var. ma‐yuen Stapf.) in rats fed a high‐cholesterol diet. Int J Food Sci Nutr. 2015;66(7):783‐789. [DOI] [PubMed] [Google Scholar]
  • 18. Katsarou AI, Kaliora AC, Chiou A, et al. Amelioration of oxidative and inflammatory status in hearts of cholesterol‐fed rats supplemented with oils or oil‐products with extra virgin olive oil components. Eur J Nutr. 2016;55(3):1283‐1296. [DOI] [PubMed] [Google Scholar]
  • 19. Sawale PD, Pothuraju R, Abdul Hussain S, Kumar A, Kapila S, Patil GR. Hypolipidaemic and anti‐oxidative potential of encapsulated herb (Terminalia arjuna) added vanilla chocolate milk in high cholesterol fed rats. J Sci Food Agric. 2016;96(4):1380‐1385. [DOI] [PubMed] [Google Scholar]
  • 20. González‐Peña D, Checa A, de Ancos B, Wheelock CE, Sánchez‐Moreno C. New insights into the effects of onion consumption on lipid mediators using a diet‐induced model of hypercholesterolemia. Redox Biol. 2017;11:205‐212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. González‐Peña D, Giménez L, de Ancos B, Sánchez‐Moreno C. Role of dietary onion in modifying the faecal bile acid content in rats fed a high‐cholesterol diet. Food Funct. 2017;8(6):2184‐2192. [DOI] [PubMed] [Google Scholar]
  • 22. Ampawong S, Isarangkul D, Aramwit P. Sericin ameliorated dysmorphic mitochondria in high‐cholesterol diet/streptozotocin rat by antioxidative property. Exp Biol Med. 2017;242(4):411‐421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Balzan S, Hernandes A, Reichert CL, et al. Lipid‐lowering effects of standardized extracts of Ilex paraguariensis in high‐fat‐diet rats. Fitoterapia. 2013;86:115‐122. [DOI] [PubMed] [Google Scholar]
  • 24. de las Heras N, Valero‐Muñoz M, Ballesteros S, et al. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet. Nutr Metab Cardiovasc Dis. 2013;23(11):1107‐1114. [DOI] [PubMed] [Google Scholar]
  • 25. Li M, Shu X, Xu H, et al. Integrative analysis of metabolome and gut microbiota in diet‐induced hyperlipidemic rats treated with berberine compounds. J Transl Med. 2016;14(1):237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S. Vasa vasorum anti‐angiogenesis through H2O2, HIF‐1α, NF‐κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol‐diet‐given Rattus norvegicus Wistar strain. Vasc Health Risk Manag. 2014;10:523‐531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Boudjeko T, Ngomoyogoli JEK, Woguia AL, Yanou NN. Partial characterization, antioxidative properties and hypolipidemic effects of oilseed cake of Allanblackia floribunda and Jatropha curcas . BMC Complement Altern Med. 2013;13:352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Wang YX, Li Y, Sun AM, Wang FJ, Yu GP. Hypolipidemic and antioxidative effects of aqueous enzymatic extract from rice bran in rats fed a high‐fat and ‐cholesterol diet. Nutrients. 2014;6(9):3696‐3710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Santos‐López JA, Garcimartín A, López‐Oliva ME, et al. Chia oil–enriched restructured pork effects on oxidative and inflammatory status of aged rats fed high cholesterol/high fat diets. J Med Food. 2017;20(5):526‐534. [DOI] [PubMed] [Google Scholar]
  • 30. Gujjala S, Putakala M, Ramaswamy R, Desireddy S. Preventive effect of Caralluma fimbriata vs. Metformin against high‐fat diet‐induced alterations in lipid metabolism in Wistar rats. Biomed Pharmacother. 2016;84:215‐223. [DOI] [PubMed] [Google Scholar]
  • 31. Tunsophon S, Chootip K (2016). Comparative effects of piperine and simvastatin in fat accumulation and antioxidative status in high fat‐induced hyperlipidemic rats. Can J Physiol Pharmacol. 94(12), 1344‐1348. [DOI] [PubMed] [Google Scholar]
  • 32. Tuzcu Z, Orhan C, Sahin N, Juturu V, Sahin K. Cinnamon polyphenol extract inhibits hyperlipidemia and inflammation by modulation of transcription factors in high‐fat diet‐fed rats. Oxid Med Cell Longev. 2017;2017:1‐10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. El‐Mahmoudy A, Shousha S, Abdel‐Maksoud H, Zaid OA. Effect of long‐term administration of sildenafil on lipid profile and organ functions in hyperlipidemic rats. Acta Biomedica. 2013;84(1):12‐22. [PubMed] [Google Scholar]
  • 34. Ben Gara A, Ben Abdallah Kolsi R, Chaaben R, et al. Inhibition of key digestive enzymes related to hyperlipidemia and protection of liver‐kidney functions by Cystoseira crinita sulphated polysaccharide in high‐fat diet‐fed rats. Biomed Pharmacother. 2017;85:517‐526. [DOI] [PubMed] [Google Scholar]
  • 35. Harrabi B, Athmouni K, Hamdaoui L, et al. Polysaccharides extraction from Opuntia stricta and their protective effect against HepG2 cell death and hypolipidaemic effects on hyperlipidaemia rats induced by high‐fat diet. Arch Physiol Biochem. 2017;123(4):225‐237. [DOI] [PubMed] [Google Scholar]
  • 36. Wu Y, Tan X, Tian J, et al. PPARγ agonist ameliorates the impaired fluidity of the myocardial cell membrane and cardiac injury in hypercholesterolemic rats. Cardiovasc Toxicol. 2017;17(1):25‐34. [DOI] [PubMed] [Google Scholar]
  • 37. Garcimartín A, Santos‐López JA, Bastida S, Benedí J, Sánchez‐Muniz FJ. Silicon‐enriched restructured pork affects the lipoprotein profile, VLDL oxidation, and LDL receptor gene expression in aged rats fed an atherogenic diet. J Nutr. 2015;145(9):2039‐2045. [DOI] [PubMed] [Google Scholar]
  • 38. Chijimatsu T, Umeki M, Kataoka Y, et al. Lipid components prepared from a freshwater Clam (Corbicula fluminea) extract ameliorate hypercholesterolaemia in rats fed high‐cholesterol diet. Food Chem. 2013;136(2):328‐334. [DOI] [PubMed] [Google Scholar]
  • 39. Shaodong C, Haihong Z, Manting L, Guohui L, Zhengxiao Z, Ym Z. Research of influence and mechanism of combining exercise with diet control on a model of lipid metabolism rat induced by high fat diet. Lipids Health Dis. 2013;12(1):21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Schultz Moreira AR, Benedi J, Bastida S, Sánchez‐Reus I, Sánchez‐Muniz FJ. Nori‐and Sea spaghetti‐but not Wakame‐restructured pork decrease the hypercholesterolemic and liver proapototic short‐term effects of high‐dietary cholesterol consumption. Nutr Hosp Nutr Hosp. 2013;28(5):1422‐1429. [DOI] [PubMed] [Google Scholar]
  • 41. Csont T, Sárközy M, Szcs G, et al. Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet. Lipids Health Dis. 2013;12(1):138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Pandian V, Aravindan N, Subramanian S, Somasundaran ST. Lipid‐lowering effect of molluscan (Katelysia opima) glycosaminoglycan (GAG) in hypercholesterolemic induced rats. Biol Chem. 2014;395(3):355‐364. 10.1515/hsz-2013-0214 [DOI] [PubMed] [Google Scholar]
  • 43. Bunnoy A, Saenphet K, Lumyong S, Saenphet S, Chomdej S. Monascus purpureus‐fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet‐induced hypercholesterolemic rats. BMC Complement Altern Med. 2015;15(1):88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Kansal SK, Jyoti U, Sharma S, Kaura A, Deshmukh R, Goyal S. Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart. Naunyn‐Schmiedeberg’s Arch Pharmacol. 2015;388(6):635‐641. [DOI] [PubMed] [Google Scholar]
  • 45. El‐Tantawy WH, Temraz A, Hozaien HE, El‐Gindi OD, Taha KF. Anti‐hyperlipidemic activity of an extract from roots and rhizomes of Panicum repens L. on high cholesterol diet‐induced hyperlipidemia in rats. Zeitschrift für Naturforschung C. 2015;70(5‐6):139‐144. [DOI] [PubMed] [Google Scholar]
  • 46. Song JJ, Tian WJ, Kwok LY, et al. Effects of microencapsulated Lactobacillus plantarum LIP‐1 on the gut microbiota of hyperlipidaemic rats. Br J Nutr. 2017;118(7):481‐492. [DOI] [PubMed] [Google Scholar]
  • 47. De Las Heras N , Valero‐Muñoz M, Martín‐Fernández B, et al. Molecular factors involved in the hypolipidemic and insulin sensitizing effects of a ginger (Zingiber officinale Roscoe) extract in rats fed a high‐fat diet. Appl Physiol Nutr Metab. 2017;42(2):209‐215. [DOI] [PubMed] [Google Scholar]
  • 48. Yang YH, Yang J, Jiang QH. Hypolipidemic effect of gypenosides in experimentally induced hypercholesterolemic rats. Lipids Health Dis. 2013;12(1):154. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES